Skip to search formSkip to main contentSkip to account menu

Fluocinolone Acetonide 0.00025 MG/MG Topical Ointment

Known as: FLUOCINOLONE ACETONIDE 0.025% OINT, fluocinolone acetonide 0.25 mg in 1 g TOPICAL OINTMENT [Fluocinolone Acetonide], FLUOCINOLONE ACETONIDE 0.025% OINT,TOP [VA Product] 
National Institutes of Health

Related topics

Related topics

17 relations

Broader (1)

ANTI-INFLAMMATORY,TOPICAL
Decreased Protein Synthesis [PE]Dermatitis, AtopicFacial DermatosesFluocinolone Acetonide

Narrower (1)

Fluocinolone Acetonide 0.00025 MG/MG Topical Ointment [Synalar]

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Effect of fluocinolone acetonide 0.2 μg/day implant on the decision to drive in patients with diabetic macular oedema: a report from the FAME study
Objective This study aimed to determine whether treatment with the 0.2 µg/day fluocinolone acetone implant (FAc; ILUVIEN, Alimera… 
2017
2017
Report of 12-months efficacy and safety of intravitreal fluocinolone acetonide implant for the treatment of chronic diabetic macular oedema: a real-world result in the United Kingdom
PurposeTo report the 12-months visual and anatomical outcomes of chronic diabetic macular oedema (DMO) treated with ILUVIEN in a… 
2017
2017
The first European report of real-life clinical outcomes after 3 years of treatment with ILUVIEN® (fluocinolone acetonid) in patients with chronic diabetic macular edema (DME)
Review
2016
Review
2016
Fluocinolone acetonide for the treatment of diabetic macular edema
ABSTRACT In addition to VEGF inhibitors such as ranibizumab, aflibercept or bevacizumab, clinical and experimental investigations… 
2015
2015
Liquid chromatography/tandem mass spectrometry for simultaneous determination of undeclared corticosteroids in cosmetic creams.
RATIONALE Undeclared corticosteroids in creams intended for frequent use might cause serious side-effects, especially in children… 
2007
2007
Vitreous band formation and the sustained-release, intravitreal fluocinolone (Retisert) implant.
corneas. Invest Ophthalmol Vis Sci. 2000;41: 2514-2522. 3. Maguire MG, Stark WJ, Gottsch JD, et al. Risk factors for corneal… 
1997
1997
Glucocorticosteroids inhibit degradation in bovine cartilage explants stimulated with concomitant plasminogen and interleukin-1
Abstract.Objective: Glucocorticosteroids are beneficial in the treatment of osteoarthritis (OA) in humans, and have been shown to… 
1996
1996
Mechanism of skin tumorigenesis by contact sensitizers: the effect of the corticosteroid fluocinolone acetonide on inflammation and tumor induction by 2,4 dinitro-1-fluorobenzene in the skin of the…
The effect of the corticosteroid fluocinolone acetonide (FA) on skin tumor induction and inflammation by the contact sensitizer… 
1987
1987
Tumor-promoting phorbol esters cause a stable reduction of dermal collagen in mouse skin.
1967
1967
[Studies on the stability of fluocinolone-acetenide in pharmaceutical preparations].
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)